American Portfolios Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $359K | Sell |
7,216
-1,258
| -15% | -$62.7K | 0.02% | 775 |
|
|
2022
Q2 | $472K | Buy |
8,474
+376
| +5% | +$20.9K | 0.02% | 682 |
|
|
2022
Q1 | $450K | Sell |
8,098
-484
| -6% | -$26.9K | 0.02% | 781 |
|
|
2021
Q4 | $481K | Buy |
8,582
+1,030
| +14% | +$57.7K | 0.02% | 757 |
|
|
2021
Q3 | $363K | Buy |
7,552
+1,232
| +19% | +$59.1K | 0.01% | 856 |
|
|
2021
Q2 | $265K | Buy |
6,320
+210
| +3% | +$8.8K | 0.01% | 985 |
|
|
2021
Q1 | $206K | Buy |
6,110
+16
| +0.3% | +$539 | 0.01% | 1007 |
|
|
2020
Q4 | $213K | Buy |
6,094
+164
| +3% | +$5.73K | 0.01% | 862 |
|
|
2020
Q3 | $206K | Buy |
5,930
+1,554
| +36% | +$53.9K | 0.01% | 781 |
|
|
2020
Q2 | $143K | Buy |
4,376
+206
| +5% | +$6.74K | 0.01% | 863 |
|
|
2020
Q1 | $126K | Sell |
4,170
-278
| -6% | -$8.37K | 0.01% | 814 |
|
|
2019
Q4 | $129K | Buy |
4,448
+1,388
| +45% | +$40.2K | 0.01% | 928 |
|
|
2019
Q3 | $79.1K | Buy |
3,060
+164
| +6% | +$4.24K | 0.01% | 1101 |
|
|
2019
Q2 | $73.9K | Buy |
2,896
+20
| +0.7% | +$510 | 0.01% | 1114 |
|
|
2019
Q1 | $75.2K | Buy |
2,876
+424
| +17% | +$11.1K | 0.01% | 1009 |
|
|
2018
Q4 | $56.5K | Buy |
2,452
+466
| +23% | +$10.7K | 0.01% | 961 |
|
|
2018
Q3 | $46.8K | Sell |
1,986
-2,006
| -50% | -$47.3K | 0.01% | 1141 |
|
|
2018
Q2 | $92.1K | Sell |
3,992
-3,260
| -45% | -$75.2K | 0.01% | 834 |
|
|
2018
Q1 | $179K | Buy |
7,252
+1,394
| +24% | +$34.3K | 0.03% | 560 |
|
|
2017
Q4 | $157K | Buy |
+5,858
| New | +$157K | 0.02% | 587 |
|